3.451
price up icon4.26%   0.141
 
loading
Hcw Biologics Inc stock is traded at $3.451, with a volume of 16,783. It is up +4.26% in the last 24 hours and down -20.12% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
See More
Previous Close:
$3.31
Open:
$3.34
24h Volume:
16,783
Relative Volume:
0.13
Market Cap:
$4.97M
Revenue:
$3.50M
Net Income/Loss:
$-37.33M
P/E Ratio:
-3.451
EPS:
-1
Net Cash Flow:
$-19.15M
1W Performance:
-15.62%
1M Performance:
-20.12%
6M Performance:
-77.88%
1Y Performance:
-79.51%
1-Day Range:
Value
$3.321
$3.48
1-Week Range:
Value
$2.77
$4.32
52-Week Range:
Value
$2.77
$100.80

Hcw Biologics Inc Stock (HCWB) Company Profile

Name
Name
Hcw Biologics Inc
Name
Phone
954-842-2024
Name
Address
2929 N COMMERCE PKWY, MIRAMAR
Name
Employee
36
Name
Twitter
Name
Next Earnings Date
2025-04-01
Name
Latest SEC Filings
Name
HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HCWB
Hcw Biologics Inc
3.451 10.20M 3.50M -37.33M -19.15M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Hcw Biologics Inc Stock (HCWB) Latest News

pulisher
Aug 20, 2025

HCW Biologics Faces Nasdaq Non-Compliance Notice - MSN

Aug 20, 2025
pulisher
Aug 19, 2025

HCW Biologics: Navigating Turbulence in the CAR-T Space—A High-Risk, High-Reward Biotech Play - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

HCW Biologics receives Nasdaq delisting notice, plans to request hearing - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Using economic indicators to assess HCW Biologics Inc. potentialPortfolio Value Summary & Safe Capital Growth Stock Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can HCW Biologics Overcome Liquidity and Legal Risks to Deliver Value? - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

What to do if you’re stuck in HCW Biologics Inc.Portfolio Growth Summary & Long-Term Growth Portfolio Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

HCW Biologics Inc. stock outlook for YEAR2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Detecting support and resistance levels for HCW Biologics Inc.Market Rally & Long-Term Growth Stock Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can HCW Biologics Inc. rally from current levelsQuarterly Trade Report & Weekly Setup with High ROI Potential - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

HCW Biologics 2025 Q2 Earnings Net Loss Narrows 87.4% - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

HCW Biologics Inc. Sees Relief Buying After Extended DropPrice Action & Daily Entry Point Alerts - 선데이타임즈

Aug 18, 2025
pulisher
Aug 18, 2025

Hcw Biologics says substantial doubt exists regarding ability to continue as going concern for at least 12 months - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Clinical-Stage Biotech HCW Biologics Secures $5M Funding for Novel Autoimmune Disease Treatment Trial - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Applying Wyckoff theory to HCW Biologics Inc. stockMarket Growth Review & Fast Exit and Entry Trade Guides - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Real time breakdown of HCW Biologics Inc. stock performanceEntry Point & Safe Entry Zone Tips - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Does HCW Biologics Inc. stock benefit from AI growthWeekly Gains Report & Entry and Exit Point Strategies - mustnews.co.kr

Aug 17, 2025
pulisher
Aug 17, 2025

HCW Biologics Inc.’s volatility index tracking explainedJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Why HCW Biologics Inc. stock attracts strong analyst attentionMarket Trend Summary & Risk Controlled Daily Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What drives HCW Biologics Inc.’s stock priceM&A Rumor & Low Volatility Stock Recommendations - classian.co.kr

Aug 17, 2025
pulisher
Aug 17, 2025

HCW Biologics Amends Equity Purchase Agreement - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Best data tools to analyze HCW Biologics Inc. stockPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Fibonacci Retracement Aligns with Support in HCW Biologics Inc.2025 Sector Review & Short-Term High Return Ideas - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Is HCW Biologics Inc. stock poised for growthWeekly Stock Recap & Target Return Focused Picks - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will HCW Biologics Inc. stock benefit from interest rate changesTrade Risk Report & Low Risk High Reward Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

HCW Biologics Second Quarter 2025 Earnings: US$0.90 loss per share (vs US$16.16 loss in 2Q 2024) - Yahoo Finance

Aug 16, 2025
pulisher
Aug 16, 2025

Will HCW Biologics Inc. rebound enough to break evenMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

HCW Biologics Delays Q2 10-Q Filing - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Exit strategy if you’re trapped in HCW Biologics Inc.Analyst Downgrade & Risk Controlled Daily Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will HCW Biologics Inc. price bounce be sustainable2025 Retail Activity & Daily Profit Focused Stock Screening - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Is HCW Biologics Inc. reversing from oversold territoryJuly 2025 PreEarnings & Long-Term Investment Growth Plans - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Hcw Biologics Reports Q2 2025 Earnings: Revenue Down 98%, Net Loss Improves to $1.9 Million - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Hcw Biologics Revenue Plunges 98 Percent - The Globe and Mail

Aug 14, 2025
pulisher
Aug 14, 2025

Hcw Biologics Revenue Plunges 98 Percent - The Motley Fool

Aug 14, 2025
pulisher
Aug 14, 2025

Published on: 2025-08-14 21:23:14 - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Long term hold vs stop loss in HCW Biologics Inc.Gap Up & Stepwise Entry and Exit Trade Signals - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

What moving averages say about HCW Biologics Inc.Gap Up & AI Forecast Swing Trade Picks - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

What recovery options are there for HCW Biologics Inc.Risk Management & Free Expert Verified Stock Movement Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Market reaction to HCW Biologics Inc.’s recent newsAnalyst Downgrade & Weekly Setup with ROI Potential - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

HCW Biologics Inc. stock chart pattern explainedQuarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser

Aug 13, 2025

Hcw Biologics Inc Stock (HCWB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Hcw Biologics Inc Stock (HCWB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Winer Gary M
Director
May 16 '25
Buy
7.45
1,342
9,998
4,075
GARRETT SCOTT T
Director
May 16 '25
Buy
7.45
13,423
100,001
25,505
Winer Gary M
Director
May 08 '25
Buy
26.00
2,308
60,008
2,733
Wong Hing C
Chief Executive Officer
May 08 '25
Buy
26.00
92,500
2,405,000
493,857
GARRETT SCOTT T
Director
May 08 '25
Buy
26.00
5,385
140,010
12,082
Byam Rebecca
Chief Financial Officer
May 08 '25
Buy
26.00
8,462
220,012
43,010
Flowers Lee
SVP of Business Development
May 08 '25
Buy
26.00
962
25,012
5,720
Greene Rick S.
Director
May 08 '25
Buy
26.00
962
25,012
2,066
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):